Clinical Trial Update: Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure [NA]

View source ↗

Summary

The clinical trial evaluated the sensitivity of the InSync Sentry OptiVol feature in predicting heart failure events; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure, Congestive | NA | Status: COMPLETED | Results posted: 2018-10-22